Work

Phase I study of procaspase activating compound-1 (PAC-1) for treatment of advanced malignancies.

Year: 2018

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2018.36.15_suppl.tps2621

Authors: Oana C. Danciu, Martin Kelly Nicholas, Matthias Holdhoff, Richard A. Peterson, Theodore M Tarasow, Paul J. Hergenrother, Arkadiusz Z. Dudek

Institutions: University of Illinois Chicago, Johns Hopkins University, Sidney Kimmel Comprehensive Cancer Center, HealthPartners, Vanquish Oncology (United States)

Language: English

Topic: Cell death mechanisms and regulation

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4239142255

Cites:

Cited by: 3

Related to: 10